Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;16(1):55-65.
doi: 10.1007/s41999-024-01111-w. Epub 2024 Dec 2.

Sex differences in the association between sarcopenia index and sarcopenia: a cross-sectional study from a Chinese community-based population

Affiliations

Sex differences in the association between sarcopenia index and sarcopenia: a cross-sectional study from a Chinese community-based population

Hong Yang et al. Eur Geriatr Med. 2025 Feb.

Abstract

Purpose: The sarcopenia index (SI) is a convenient method to screen for sarcopenia, but few studies have analysed whether there are sex differences. The aim of this study was to analyse sex differences in the relationship between SI and sarcopenia in a Chinese community-based population.

Methods: This cross-sectional study included participants from 2011 China Health and Retirement Longitudinal Study. The SI was defined as 100 × creatinine / cystatin C. Diagnosis of sarcopenia based on the Asian Working Group for Sarcopenia 2019 consensus. Logistic regression model, linear regression model, and natural spline model were used to analyze the association between SI and sarcopenia.

Results: A total of 7,118 participants with a mean age of 60.6 ± 10.1 were included, 53.4% females. In males, the prevalence of sarcopenia decreased by 25% for every 10 increase in SI, and skeletal muscle mass index (SMI) increased by 0.04, odds ratio (OR), β, and 95% confidence interval (CI) were 0.75 (0.65-0.87), 0.04 (0.02-0.05), both P < 0.001. In females, the SI was not significantly associated with sarcopenia, OR and 95% CI were 0.99 (0.9 ~ 1.08), P = 0.775; for every 10 increase in SI, the SMI in females decreased by 0.03, β and 95% CI were -0.03 (-0.04 ~ -0.01), P = 0.001.

Conclusion: In the Chinese community, the SI is negatively associated with sarcopenia in males and has moderate diagnostic test performance. It was not associated with sarcopenia in females, and using the SI to screen for sarcopenia in females may not be a reliable method.

Keywords: CHARLS; Creatinine; Cystatin C; Sarcopenia; Sarcopenia index.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare that they have no conflict of interest. Ethical approval: The CHARLS study was approved by the Ethical Review Committee of Peking University (IRB00001052-11015). All methods were carried out in accordance with relevant guidelines and regulations. Informed consent: Informed consent was obtained from all subjects.

Figures

Fig. 1
Fig. 1
Flow chart of the screening of participants
Fig. 2
Fig. 2
Multivariate analyses forest plot of the association of SI with sarcopenia (a), SMI (b), gait speed (c), 5-time chair stand test (d), and handgrip strength (e), with the SI as a continuous variable (per 10) and a categorical variable. The blue and pink colours represent males and females respectively, the squares represent OR or β, the lines represent 95% CI. Adjusted for: age, education, marital, residence, smoking, alcohol consumption, hypertension, dyslipidemia, diabetes, cancer, chronic lung diseases, liver disease, heart disease, stroke, kidney disease, digestive disease, emotional problems, memory related disease, arthritis, asthma, BUN, TG, HDL-c, LDL-c, CRP, UA, HB, eGFR. OR odds ratio; CI confidence interval; SI Sarcopenia Index; SMI skeletal muscle mass index; BUN blood urea nitrogen; TG total triglycerides; HDL-c high-density lipoprotein cholesterol; LDL-c low density lipoprotein cholesterol; CRP high sensitivity C-reactive protein; UA uric acid; HB hemoglobin; eGFR estimated glomerular filtration rate.
Fig. 3
Fig. 3
Natural spline model of the association of SI with sarcopenia (a), SMI (b), gait speed (c), 5-time chair stand test (d), and handgrip strength (e). The blue and pink colours represent males and females, respectively; the lines represent trends; and the coloured areas around them represent the 95% CI. Only 98% participants were included, with a knot of 4. Adjusted for: age, education, marital, residence, smoking, alcohol consumption, hypertension, dyslipidemia, diabetes, cancer, chronic lung diseases, liver disease, heart disease, stroke, kidney disease, digestive disease, emotional problems, memory related disease, arthritis, asthma, BUN, TG, HDL-c, LDL-c, CRP, UA, HB, eGFR. SI Sarcopenia Index; SMI skeletal muscle mass index; CI confidence interval; BUN blood urea nitrogen; TG total triglycerides; HDL-c high-density lipoprotein cholesterol; LDL-c low density lipoprotein cholesterol; CRP high sensitivity C-reactive protein; UA uric acid; HB hemoglobin; eGFR estimated glomerular filtration rate
Fig. 4
Fig. 4
Subgroup forest plots of multifactorial logistic regression models for the association between SI and sarcopenia. The blue and pink colours represent males and females respectively, the squares represent OR and the lines represent 95% CI. Multivariate: adjusted for: age, education, marital, residence, smoking, alcohol consumption, hypertension, dyslipidemia, diabetes, cancer, chronic lung diseases, liver disease, heart disease, stroke, kidney disease, digestive disease, emotional problems, memory related disease, arthritis, asthma, BUN, TG, HDL-c, LDL-c, CRP, UA, HB, eGFR. OR odds ratio; CI confidence interval; SI Sarcopenia Index; BUN blood urea nitrogen; TG total triglycerides; HDL-c high-density lipoprotein cholesterol; LDL-c low density lipoprotein cholesterol; CRP high sensitivity C-reactive protein; UA uric acid; HB, hemoglobin; eGFR estimated glomerular filtration rate.
Fig. 5
Fig. 5
ROC curves for the sarcopenia index in males a an females, b SI sarcopenia index

Similar articles

References

    1. Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21:300-307.e2. 10.1016/j.jamda.2019.12.012 - PubMed
    1. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31. 10.1093/ageing/afy169 - PMC - PubMed
    1. Lin T, Jiang T, Huang X, Xu P, Liang R, Song Q et al (2024) Diagnostic test accuracy of serum creatinine and cystatin C-based index for sarcopenia: a systematic review and meta-analysis. Age Ageing 53(1):afad252 - PubMed
    1. Xu J, Wan CS, Ktoris K, Reijnierse EM, Maier AB (2022) Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology 68:361–376. 10.1159/000517099 - PubMed
    1. Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D et al (2013) Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle 4:19–29. 10.1007/s13539-012-0079-1 - PMC - PubMed

Supplementary concepts

LinkOut - more resources